Insulin potentiation therapy

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Insulin potentiation therapy (IPT) is an unproven alternative cancer treatment using insulin to administer low-dose chemotherapy.[1] It was developed by Donato Perez Garcia, MD in 1930 as a targeted therapy for chronic degenerative diseases and some types of cancer.

The American Cancer Society note of Insulin potentiation therapy that "no scientific studies that show safety and effectiveness have been published in available peer-reviewed journals."[2]

According to Quackwatch, "Insulin Potentiation Therapy (IPT) is one of several unproven, dangerous treatments that is promoted by a small group of practitioners without trustworthy evidence that it works."[3]

See also[edit]

References[edit]

  1. ^ Ayre SG, Perez Garcia y Bellon D, Perez Garcia D (1986). "Insulin potentiation therapy: a new concept in the management of chronic degenerative disease". Med. Hypotheses 20 (2): 199–210. doi:10.1016/0306-9877(86)90126-X. PMID 3526099. 
  2. ^ "Insulin Potentiation Therapy". American Cancer Society. 1 November 2008. Retrieved August 2013. 
  3. ^ Baratz, Robert (10 March 2007). "Why You Should Stay Away from Insulin Potentiation". Quackwatch. Retrieved 11 December 2012.